- In August 2024, Terumo India, the Indian subsidiary of Japan-based Terumo Corporation, a global leader in medical technology, announced the launch of the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR)
- In July 2024, Endospan announced a new agreement with Artivion for additional loans totaling up to USD 25 million. Artivion, which operates in over 100 countries, offers a range of products including aortic stent grafts, surgical sealants, mechanical heart valves, and implantable cardiac and vascular human tissue. The funding aims to support Endospan’s efforts to secure FDA approval for its Nexus Stent Graft System
- In January 2024, W. L. Gore & Associates, Inc. (Gore) announced FDA approval for a lower-profile version of the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft). This approval enhances a device already recognized as a vital tool for managing complex vascular diseases. The updated VBX Stent Graft features the longest balloon-expandable stent on the market (79 mm), the widest range of stent diameter adjustability, and the highest number of 6 Fr compatible configurations among balloon-expandable stent grafts
- In June 2023, Endospan shared the initial European experience with its NEXUS DUO Aortic Arch Stent Graft System at the Leipzig Interventional Course (LINC). The multicenter study showcased the first ten patients treated with this custom-made system
- In May 2021, Endologix LLC announced the first implant of its ALTO Abdominal Stent Graft in Canada following Health Canada approval. The device was also recently approved for commercial sale in Argentina
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Abdominal Aortic Stent Graft and Thoracic Aortic Stent Graft), End User (Hospitals and Ambulatory Surgical Centers) – Industry Trends and Forecast to 2031
.
The Global Aortic Stent Grafts Market size was valued at USD 3.77 USD Billion in 2024.
The Global Aortic Stent Grafts Market is projected to grow at a CAGR of 5.41% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
